Suppr超能文献

肺笛改善慢性支气管炎型慢性阻塞性肺疾病的症状和健康状况:一项为期26周的随机对照试验。

Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial.

作者信息

Sethi Sanjay, Yin Jingjing, Anderson Pamela K

机构信息

VA WNY Health Care System, 3495 Bailey Avenue, Buffalo 14215, NY, USA ; University at Buffalo, Suny, Buffalo, NY, USA.

University at Buffalo, Suny, Buffalo, NY, USA.

出版信息

Clin Transl Med. 2014 Sep 23;3:29. doi: 10.1186/s40169-014-0029-y. eCollection 2014.

Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is characterized by mucus hypersecretion that contributes to disease related morbidity and is associated with increased mortality. The Lung Flute® is a new respiratory device that produces a low frequency acoustic wave with moderately vigorous exhalation to increase mucus clearance. We hypothesized that the Lung Flute, used on a twice daily basis will provide clinical benefit to patients with COPD with chronic bronchitis.

METHODS

We performed a 26 week randomized, non-intervention controlled, single center, open label trial in 69 patients with COPD and Chronic Bronchitis. The primary endpoint was change in respiratory symptoms measured with the Chronic COPD Questionnaire (CCQ). Secondary endpoints included health status, assessed by the St. George Respiratory questionnaire (SGRQ), BODE (Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity) index score and exacerbation frequency.

RESULTS

While the control patients did not demonstrate any significant changes in the primary endpoint (CCQ change at 26 weeks of +0.01, p = 0.8), a trend (p = 0.08) to decrease (improvement) in the CCQ (-0.23 at 26 weeks) was seen with the Lung Flute. Furthermore, a significant improvement in the symptom domain of the CCQ was seen only with the lung flute (-0.42, p = 0.004). Health status (SGRQ) improvement, was also only seen with the Lung Flute (-3.23, p = 0.03). The BODE score increased in the control group (3.31 at baseline, 4.14 at 26 weeks), however it remained stable in the Lung Flute arm (3.16 at baseline and 26 weeks), with the changes from baseline being significantly different between the 2 arms (p = 0.01). There was a trend for less exacerbations in the Lung Flute group (p = 0.07). Adverse effects were minor, with only 1 patient discontinuing treatment because of lack of efficacy. Serious adverse effects seen were all determined to be unrelated to the device use.

CONCLUSIONS

The Lung Flute is a safe and effective treatment in COPD with chronic bronchitis, providing a wide array of benefits.

CLINICALTRIALSGOV IDENTIFIER

NCT01186822.

摘要

背景

慢性阻塞性肺疾病(COPD)的特征是黏液分泌过多,这会导致与疾病相关的发病率增加,并与死亡率上升有关。肺笛是一种新型呼吸装置,通过适度用力呼气产生低频声波以增加黏液清除。我们假设,每天使用两次肺笛将对患有慢性支气管炎的COPD患者产生临床益处。

方法

我们对69例患有COPD和慢性支气管炎的患者进行了一项为期26周的随机、非干预对照、单中心、开放标签试验。主要终点是用慢性阻塞性肺疾病问卷(CCQ)测量的呼吸症状变化。次要终点包括健康状况,通过圣乔治呼吸问卷(SGRQ)、BODE(体重指数、气流阻塞、呼吸困难和运动能力)指数评分以及急性加重频率进行评估。

结果

虽然对照组患者在主要终点方面没有表现出任何显著变化(26周时CCQ变化为+0.01,p = 0.8),但使用肺笛组的CCQ有下降(改善)趋势(p = 0.08)(26周时为-0.23)。此外,仅在使用肺笛组观察到CCQ症状领域有显著改善(-0.42,p = 0.004)。健康状况(SGRQ)的改善也仅在使用肺笛组中观察到(-3.23,p = 0.03)。对照组的BODE评分增加(基线时为3.31,26周时为4.14),然而在肺笛组中保持稳定(基线和26周时均为3.16),两组从基线的变化有显著差异(p = 0.01)。肺笛组急性加重有减少趋势(p = 0.07)。不良反应轻微,只有1例患者因缺乏疗效而停止治疗。观察到的严重不良反应均被确定与使用该装置无关。

结论

肺笛对患有慢性支气管炎的COPD是一种安全有效的治疗方法,具有多种益处。

临床试验注册号

NCT01186822。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1b/4299801/79117dc220b4/s40169-014-0029-y-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验